The trajectory of Viagra presents a complex case for observers in the drug sector. While initially a blockbuster success, generating vast sums, the intellectual property expiration and the subsequent arrival of cheaper alternatives have significantly affected revenue. This poses questions about the long-term sustainability of similar therapeutic… Read More